My own bio-imprint as asset for competitive advantage

Project Information

MYBIOASSET

Grant agreement ID: 711328

DOI

10.3030/711328

Project closed

EC signature date 30 November 2015

Start date 1 December 2015

End date 31 May 2016

Funded under

• INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Biotechnology

Total cost

€ 71 429,00

EU contribution

€ 50 000,00

Coordinated by

INBIOLEV SL
Spain

Periodic Reporting for period 1 - MYBIOASSET (My own bio-imprint as asset for competitive advantage)

Reporting period: 2015-12-01 to 2016-05-31

Summary of the context and overall objectives of the project

LEV2050 has developed and tested MYBIOASSETS, a method, procedure and technology to genetically select, preserve and reproduce indigenous yeasts, from different strains and genders. With this technology, wineries can create their own, unique wines with special characteristics provided by their own yeasts, selected from their vineyards, and reproduce those special flavours year after year making a difference among their competitors. MYBIOASSETS has been tested in several wineries in Spain with excellent results. The tailored engineered bioreactors designed by LEV2050 will help wineries to reproduce year after year the selected yeasts maintaining the highest level of quality.

Work performed from the beginning of the project to the end of the period covered by the report and main results achieved so far

"""The feasibility study has been carried out during 2016 and covers nex sections: MARKET STUDY AND INVOLVEMENT OF KEY STAKEHOLDERS: - Market features
- Value chain
- Market segments
- Opportunity
- Competition
- Regulation
- Commercialisation
- Risks
- Time to market FREEDOM TO OPERATE, VALUE PROPOSITION AND BUSINESS MODEL - Product/service
- Differentiation
- IPR
- Prospective
- Business model COST, REVENUES AND FUNDING SCHEME""
"

Progress beyond the state of the art and expected potential impact (including the socio-economic impact and the wider societal implications of the project so far)

In comparison to competition products, MYBIOASSETS has a wider potential of differenciation. Instead of use commercial yeasts present in the market, each winery has the opportunity to select those yeasts present in their vineyards that provide wines with the most desirable organoleptic qualities. This differenciation allows wineries to make a difference in the market, improving sales expectations. With the help of tailored bioreactors, yeast cost per campaign will be affordable for wineries, independently from their size.

lev2050-2.png

lev2050-1.png